Emmanuel S. Burgos
Melinta Therapeutics (United States)
ORCID: 0000-0003-4555-7673Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Boosting NAD+ with a small molecule that activates NAMPT”.
Meghan Hopf, Asima Khan, Mauro Dispagna, E. Hampton Sessions, Rebecca Falter +13 more
Emmanuel S. Burgos, Varun Gupta, Alyssa D. Casill, Brian Kosmyna, Hongshan Chen +4 more
Rajesh K. Harijan, Emmanuel S. Burgos, J.B. Bonanno, Steven C. Almo, David Shechter +1 more
Rajesh K. Harijan, Emmanuel S. Burgos, J.B. Bonanno, Steven C. Almo, David Shechter +1 more
Hongshan Chen, Emmanuel S. Burgos, Maxim I. Maron, Sitaram Gayatri, Edward Nieves +11 more